galena biopharma inc
(GALE:Consolidated Issue listed on NASDAQ Capital Market)
Mark W. Schwartz Ph.D.
Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee, Galena Biopharma, Inc.
|Age||Total Calculated Compensation||This person is connected to 20 board members in 2 different organizations across 4 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Mark W. Schwartz, Ph.D., has been the Chief Executive Officer and President of Galena Biopharma, Inc. since August 2014. Dr. Schwartz served as the Chief Operating Officer and Executive Vice President at Galena Biopharma, Inc., since April 2011 until August 2014. Dr. Schwartz served as the Chief Executive Officer and President at Apthera, Inc. since January 2010. Dr. Schwartz served as the Chief Executive Officer and President of Bayhill Therapeutics Inc. from March ...
4640 SW Macadam AvenuePhone: 855-855-4253
Portland, Oregon 97239
Fax: 503- 400-6611
Board Members Memberships*
Former Chief Executive Officer and President
Chief Executive Officer, President and Director
Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee
Arizona State University-Tempe
|Ali Mortazavi||Chief Executive and Director|
Silence Therapeutics plc
|Mark A. Sirgo Pharm.D.||Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee|
BioDelivery Sciences International, Inc.
|Peter French B.Sc, M.Sc, Ph.D., MBA||Chief Executive Officer, Managing Director and Director|
Benitec Biopharma Limited
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|Paul C. Grint M.D.||Chief Executive Officer, President and Director|
Regulus Therapeutics Inc.
|--||Compensation as of Fiscal Year 2013.|